Brief: Galapagos NV Says FY Operating Loss EUR 188.3 Million
Feb 12 (Reuters) - Galapagos NV GLPG.AS :
* GALAPAGOS NV - FY OPERATING LOSS EUR 188.3 MILLION
* GALAPAGOS NV - EXPECTS ITS NORMALIZED ANNUAL CASH BURN TO
BE
BETWEEN EUR 175 MILLION AND EUR 225 MILLION, EXCLUDING
RESTRUCTURING COSTS
* GALAPAGOS NV - FY NET LOSS FROM CONTINUING OPERATIONS EUR
1.3
MILLION
* GALAPAGOS NV - UPON SEPARATION, GALAPAGOS EXPECTS TO HAVE
APPROXIMATELY EUR 500 MILLION IN CASH TO ACCELERATE ITS PIPELINE
AND FUND ITS OPERATIONS TO 2028
Source text: ID:nGNEbY80Rg
Further company coverage: GLPG.AS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lakefront Biotherapeutics NV
See all newsBrief: Lakefront Announces Sale Of Preclinical Car-T Programs To Armed Cell Therapeutics
RBC upgrades Lakefront Biotherapeutics to 'outperform' on gamgertamig prospect
Brief: U.S. FDA Grants Orphan Drug Designation To Gamgertamig For The Treatment Of Pemphigus
Brief: Lakefront Biotherapeutics H1 Net Profit From Continuing Operations €15.8 Mln
Brief: Gilead Sciences and Lakefront Complete Acquisition of Ouro Medicines to Further Expand Inflammation Pipeline